Approvals/TGA/COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection multidose vial

Approved

STANDARD

COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection multidose vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e0de9bbd18d7cc49
Product Name: COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection multidose vial
Artg Id: 457680
Artg Name: COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection multidose vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2024-10-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c6e737e5c5f5973766879b959fcd0bce.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/10509e46e194184071ec7a3dcc3b3b7a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

e0de9bbd18d7cc49

Type

Standard